VIENNA, Va., April 23, 2024--CEL-SCI appoints Mario Gobbo to its Board of Directors.
VIENNA, Va., March 19, 2024--CEL-SCI’s LEAPS vaccine offers promising new paradigm to treat rheumatoid arthritis: published in Frontiers in Immunology.
VIENNA, Va., March 06, 2024--CEL-SCI Corporation issues letter to shareholders.